Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial

Rina Hui, Edward B. Garon, J.W. Goldman et al. · Annals of Oncology · 2017

Cited by 237 works. doi:10.1093/annonc/mdx008 Open-access PDF

Authors

References